Keeping Nursing Home Residents and Staff Safe in the Era of COVID-19: A Webinar
Source: National Academies of Sciences, Engineering, and Medicine. Published: 4/22/2020. This 54-minute webinar, sponsored by the National Academies of Sciences, Engineering, and Medicine ’s Roundtable on Quality Care for People with Serious Illness, Board on Population Health and Public Health Practice, and the Forum on Aging, Disability, and Independence, highlights the innovative approaches to address the complex challenges during the COVID-19 pandemic for nursing homes that are currently being implemented in the state of Maryland. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Rapid COVID-19 Vaccine Development: An Example of the Prototype Pathogen Approach for Pandemic Preparedness
Source: National Institute of Allergy and Infectious Diseases [National Institutes of Health] (NIAID). Published: 4/22/2020. In this one-hour presentation, the speaker discusses the prototype pathogen approach for pandemic preparedness that has been applied to the Middle East respiratory syndrome coronavirus (MERS CoV) over the last seven years, and explains the prototype pathogen approach in the context of developing a rapid COVID-19 vaccine. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

IDSA COVID-19 Antibody Testing Primer
Source: Infectious Diseases Society of America (IDSA). Published: 4/22/2020. As serological testing for SARS-CoV-2 advances, there are multiple issues that need to be addressed, from test quality to interpretation. This three-page document outlines the current state of antibody testing for SARS-CoV-2, along with research questions and additional testing and policy considerations. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 Testing: Possibilities, Challenges, and Ensuring Equity
Source: American Public Health Association (APHA). Published: 4/22/2020. This one-hour, 30-minute webinar, the fifth in the COVID-19 Conversations webinar series, gives an update on testing for COVID-19, what data different tests will provide, how that data can be used to inform plans to ease physical distancing, and the equity issues that must be considered regarding what populations can access testing and how to ensure equal access for all. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 Pandemic Guidance for the Health Care Sector
Source: Government of Canada. Published: 4/22/2020. This web page provides planning guidance for the delivery of health care in Canada during the COVID-19 pandemic, which is expected to result in a prolonged period of increased demand on the health care system. The primary audience is the federal/provincial/territorial (FPT) health sector, although the guidance may also be of use to regional and local health authorities, health professional associations, and others involved in the delivery of health care. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Infection Prevention and Control for COVID-19: Second Interim Guidance for Acute Healthcare Settings
Source: Government of Canada. Published: 4/22/2020. This resource builds on the foundational infection prevention and control guidance for acute healthcare settings and provides guidance specific to the COVID-19 pandemic in acute care settings. Additional clarification is provided on certain issues (e.g., triage and facility entry points, aerosol-generating medical procedures, organizational readiness, and healthcare worker safety and training). (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Developing a National Strategy for Serology (Antibody Testing) in the United States
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 4/22/2020. Serology (antibody) tests for the SARS-CoV-2 virus have the potential to inform good public health decision-making during the COVID-19 pandemic. This 38-page report describes potential uses of the tests, areas of uncertainty where additional research is needed, and examples from other countries now beginning to make use of these tests. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: Emergency Use of Philips IntelliVue Patient Monitors MX750 and MX850, Philips IntelliVue 4-Slot Module Rack FMX-4, and Philips IntelliVue Active Displays AD75 and AD85 During the COVID-19 Pandemic
Source: U.S. Food and Drug Administration (FDA). Published: 4/22/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Philips IntelliVue Patient Monitors MX750 and MX850; Philips IntelliVue 4-Slot Module Rack FMX-4; and Philips IntelliVue Active Displays AD75 and AD85, which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. These devices are authorized for emergency use by healthcare professionals in the hospital environment for the monitoring of patients having or suspected of havi...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: Emergency Use of the oXiris Set Device for COVID-19
Source: U.S. Food and Drug Administration (FDA). Published: 4/22/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the oXiris Set device for the reduction of pro-inflammatory mediators, which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. The oXiris Set device is authorized for emergency use to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification, includi...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: RealStar ® SARS-CoV-2 RT-PCR Kit U.S. – altona Diagnostics GmbH
Source: U.S. Food and Drug Administration (FDA). Published: 4/22/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the RealStar ® SARS-CoV-2 RT-PCR Kit U.S., which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. The RealStar® SARS-CoV-2 RT-PCR Kit U.S. is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

NIAID Strategic Plan for COVID-19 Research FY2020 – FY2024
Source: National Institute of Allergy and Infectious Diseases [National Institutes of Health] (NIAID). Published: 4/22/2020. This 12-page document details the National Institute of Allergy and Infectious Diseases (NIAID)'s plan for accelerating research to diagnose, prevent, and treat COVID-19. It builds on current trans-NIAID efforts to better understand SARS-CoV-2 pathogenesis, transmission, and mechanisms of protective immunity by expanding resources and activities that support rapid development of biomedical tools to more effectively combat the COVID-19 disease and pandemic. (PDF) (Source: Disaster Lit: Resource Guid...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 in Racial and Ethnic Minority Groups
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/22/2020. This web page discusses the effects of COVID-19 on the health of racial and ethnic minority groups, including factors that influence racial and ethnic minority group health, and what can be done by governments, public health officials, healthcare providers, community organizations, and individuals. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Urban and Rural Differences in Coronavirus Pandemic Preparedness
Source: Henry J. Kaiser Family Foundation. Published: 4/22/2020. This brief analyzes variation in hospital bed capacity by region in the U.S. and by metro/non-metro status, and examines metro and non-metro differences in the share of the population that is at increased risk of COVID-19 due to age or health status. Non-metro areas are largely rural, and, even prior to the pandemic, face different challenges in health system capacity, including further travel times for patients and provider shortages. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Contact Tracing: Part of a Multi-Pronged Approach to Fight the COVID-19 Pandemic
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/22/2020. This web page highlights basic principles of contact tracing to stop COVID-19 transmission. Communities must scale up and train a large contact tracer workforce and work collaboratively across public and private agencies to stop the transmission of COVID-19. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 Workforce Virtual Toolkit: Resources for Healthcare Decision-Makers Responding to COVID-19 Workforce Concerns
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 4/22/2020. This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides a curated set of resources and tools for decision-makers managing healthcare workforce challenges in response to the COVID-19 emergency. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news